Shopping Cart

Your shopping cart is currently empty

CCT251455

Name: CCT251455
Brand: TargetMol
SKU: T14906
Price: 165 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T14906Cas No. 1400284-80-1

Alias CCT 251455

CCT251455, the mitotic kinase monopolar spindle 1 (MPS1/TTK) inhibitor, is a potent (IC50=3 nM) and specific chemical tool.

CCT251455

😃Good

Purity: 99.79%

Catalog No. T14906Alias CCT 251455Cas No. 1400284-80-1

CCT251455, the mitotic kinase monopolar spindle 1 (MPS1/TTK) inhibitor, is a potent (IC50=3 nM) and specific chemical tool.

Pack Size	Price	USA Warehouse	Global Warehouse
1 mg	$165	-	In Stock
5 mg	$413	-	In Stock
10 mg	$689	-	In Stock
25 mg	$1,490	-	In Stock
50 mg	$2,380	-	In Stock
100 mg	$3,100	-	In Stock
1 mL x 10 mM (in DMSO)	$458	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.79%

Appearance:Solid

Color:White to Yellow

Resource Download

COA HNMR LCMS

Product Introduction

Bioactivity

Description	CCT251455, the mitotic kinase monopolar spindle 1 (MPS1/TTK) inhibitor, is a potent (IC50=3 nM) and specific chemical tool.
Targets&IC50	MPS1:3 nM
In vitro	CCT251455 is a potent MPS1 inhibitor that exhibits high selectivity across a broad kinase profiling panel and excellent translation of in vitro biochemical potency to cellular potency compared to the isolated MPS1 enzyme (P-MPS1 IC50 of 0.04 μM and HCT116 GI50 of 0.16 μM).[1]
In vivo	Methods: Mice bearing HCT116 human colon cancer xenografts were treated with CCT251455 (50, 75, and 100 mg/kg, orally, twice daily). Results: CCT251455 was well tolerated at all doses and inhibited MPS1 activity in mice; the observed reduction in phospho-histone H3 inhibition was consistent with the reduction in total plasma and tumor tissue exposure measured in the same experiment. [1]
Synonyms	CCT 251455

Chemical Properties

Molecular Weight	503.98
Formula	C₂₆H₂₆ClN₇O₂
Cas No.	1400284-80-1
Smiles	O=C(OC(C)(C)C)N1C=2C=C(N=CC2C=C1C=3C=NN(C3)C)NC=4C=CC(=CC4Cl)C5=CN=CN5C
Relative Density.	1.34 g/cm3 (Predicted)

Storage & Solubility Information

Storage

keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 100 mg/mL (198.42 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (6.55 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	1.9842 mL	9.9210 mL	19.8421 mL	99.2103 mL
5 mM	0.3968 mL	1.9842 mL	3.9684 mL	19.8421 mL
10 mM	0.1984 mL	0.9921 mL	1.9842 mL	9.9210 mL
20 mM	0.0992 mL	0.4961 mL	0.9921 mL	4.9605 mL
50 mM	0.0397 mL	0.1984 mL	0.3968 mL	1.9842 mL
100 mM	0.0198 mL	0.0992 mL	0.1984 mL	0.9921 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc